Phase I dose escalation trial evaluating the pharmacokinetics, anti-human cytomegalovirus (HCMV) activity, and safety of 1263W94 in human immunodeficiency virus-infected men with asymptomatic HCMV shedding (Q39652845)
Jump to navigation
Jump to search
scientific article published on September 2002
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase I dose escalation trial evaluating the pharmacokinetics, anti-human cytomegalovirus (HCMV) activity, and safety of 1263W94 in human immunodeficiency virus-infected men with asymptomatic HCMV shedding |
scientific article published on September 2002 |
Statements
1 reference
Phase I dose escalation trial evaluating the pharmacokinetics, anti-human cytomegalovirus (HCMV) activity, and safety of 1263W94 in human immunodeficiency virus-infected men with asymptomatic HCMV shedding (English)
1 reference
Jacob P Lalezari
1 reference
Judith A Aberg
1 reference
Laurene H Wang
1 reference
Mary Beth Wire
1 reference
Richard Miner
1 reference
Wendy Snowden
1 reference
Christine L Talarico
1 reference
Shuching Shaw
1 reference
Mark A Jacobson
1 reference
W Lawrence Drew
1 reference
1 September 2002
1 reference
1 reference
Identifiers
1 reference